300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
Film
SaaS
Restaurants
Photography
Email
Payments
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Hospitality
Automotive
Sports
Legal
eSports
Construction
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Theatre
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Medical
Food and Beverage
Publishing
Music
Art
Recruiting
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Web3
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Android
Internet
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Gibraltar
Oceania
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Kuwait
Czech Republic
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Canada
Senegal
Tanzania
United Kingdom
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Bangladesh
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
ProSeed Venture Capital Fund, VC Fund

ProSeed Venture Capital Fund

VC Fund

Tel Aviv, Israel

ProSeed Venture Capital Fund is a VC fund in Tel Aviv focused on Health Care and Biotechnology. ProSeed, an established Israeli Venture Capital firm since April 2000, provides funding as well as hands-on managerial assistance and analytical support to capable technology-based enterprises.ProSeed specializes in funding companies that require early stage financial support. ProSeed, together with the Technion Research and DevelopmentFoundation (TRDF), played a central role in initiating and establishing the Technion Incubator, with major venture capital firms including, Vertex, Vitalife and Battery along with the Technion-Israel Institute of Technology.

Total investments:
9
Last investment:
Lead investor:
11%

Last updated:

Industries ProSeed Venture Capital Fund invests in

Health CareBiotechnologyAppsSaaSMedical

Stages ProSeed Venture Capital Fund invests in

Series ASeries BSeedSeries C

Countries ProSeed Venture Capital Fund invests in

IsraelUnited States

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

2 more contacts available

Investment Focus

Industry

  • Health Care 2 (22%)
  • Biotechnology 2 (22%)
  • Apps 1 (11%)
  • SaaS 1 (11%)
  • Medical 1 (11%)
See all 15 industries →

Stage

  • Series A 4 (44%)
  • Series B 2 (22%)
  • Seed 1 (11%)
  • Series C 1 (11%)

Country

  • Israel 5 (56%)
  • United States 1 (11%)

Team

NameTitleInvestmentsLinksEmail
Shai Levy
Shai Levy CEO
CEO Total investments: 2
Find email
Adina Makover Life Science Director
Life Science Director Total investments: 0 Find email
Yigal Landau Director
Director Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
EarlySense EarlySense
EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts. $13M / Series C / Jul 23, 2010
Digiflex Digiflex
DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making-Ideal for narrow webapplications printers-A great motivation to replace the traditional low quality film solution-The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track $100K / Series B / Feb 28, 2010
Digiflex Digiflex
DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making-Ideal for narrow webapplications printers-A great motivation to replace the traditional low quality film solution-The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track Series A / May 31, 2009
Correlsense Correlsense
Correlsense helps businesses achieve IT reliability by detecting degradations and outages caused by poorly performing applications. The company’s award-winning flagship product, SharePath, tracks every transaction through each hop in the data center, providing unprecedented visibility into the infrastructure. Easy to deploy and maintain,SharePath is used by businesses of all sizes to optimize the end-user experience, to minimize the risks associated with new service roll-outs and data center migration, to issue chargebacks for IT resources consumed, and to improve the capacity planning process. The company offers an Express edition of SharePath to measure the end-user experience of cloud-based and on-premise applications. This free enterprise-class software can be downloaded at http://www.real-user-monitoring.com.Correlsense was founded in 2005 and is privately held. Series B / Apr 30, 2009
Correlsense Correlsense
Correlsense helps businesses achieve IT reliability by detecting degradations and outages caused by poorly performing applications. The company’s award-winning flagship product, SharePath, tracks every transaction through each hop in the data center, providing unprecedented visibility into the infrastructure. Easy to deploy and maintain,SharePath is used by businesses of all sizes to optimize the end-user experience, to minimize the risks associated with new service roll-outs and data center migration, to issue chargebacks for IT resources consumed, and to improve the capacity planning process. The company offers an Express edition of SharePath to measure the end-user experience of cloud-based and on-premise applications. This free enterprise-class software can be downloaded at http://www.real-user-monitoring.com.Correlsense was founded in 2005 and is privately held. Series A / Jun 23, 2008
Digiflex Digiflex
DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making-Ideal for narrow webapplications printers-A great motivation to replace the traditional low quality film solution-The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track $900K / Series A / Mar 31, 2008
Vayar Vision Vayar Vision
Vayar Vision turns images to knowledge: it's a Google for pictures and images, and a missing link between pixels and text.Transform your images into searchable ones. The visual tags are compatible with environments such as Flickr and Picasa. Vayar exposes hidden, beyond words, connections and associations between images. Vayar visualsearch results can be integrated with various decision support systems, and respond to the user with information, which is attached to the found images. When pixels communicate with words- the possibilities are endless. And you are invited to join the adventure. Series A / Jan 31, 2008
APProtect APProtect
APProtect Ltd. provides anti-piracy protection solutions for consumer and business software developers and publishers. It offers Trusted Server Protection products to protect CAD tools and scientific applications in companies, universities, and other organizations; Online Software Protector family of products for protecting consumer software; andsplitting machine software, which operates on a binary and splits it into two parts. The company also provides splitting, site installation, and server hosting services. APProtect Ltd. was founded in 2004 and is based in Haifa, Israel. $750K / Series A / Jul 27, 2006
GeneGrafts GeneGrafts
GeneGrafts Ltd. is a biotechnology company developing proprietary technology for modulating excitable tissues, such as of brain or heart, by cell therapy. This new paradigm can be used for treatment of various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias.They have developed a noveltechnology platform based on transplantation of cell grafts, isolated from the patient's own body, which defines the ion channels. These grafted cells integrate functionally and structurally with the target organ, and their electrical properties are derived from the expressed ion channels. The electrical properties of target organ are modulated in a predetermined way. This technology is designed for treatment of neurological disorders and cardiac arrhythmias. $800K / Seed / Dec 17, 2003

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
Film
SaaS
Restaurants
Photography
Email
Payments
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Hospitality
Automotive
Sports
Legal
eSports
Construction
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Theatre
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Medical
Food and Beverage
Publishing
Music
Art
Recruiting
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Web3
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Android
Internet
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Gibraltar
Oceania
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Kuwait
Czech Republic
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Canada
Senegal
Tanzania
United Kingdom
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Bangladesh
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does ProSeed Venture Capital Fund invest in?

ProSeed Venture Capital Fund invests primarily in Health Care, Biotechnology and Apps startups, most often at Series A and Series B stage. Most of the 9 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact ProSeed Venture Capital Fund?

Public channels for ProSeed Venture Capital Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at ProSeed Venture Capital Fund?

The team at ProSeed Venture Capital Fund includes Shai Levy (CEO), Adina Makover (Life Science Director) and Yigal Landau (Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
ProSeed Venture Capital Fund ProSeed Venture Capital Fund Find emails